Inventor · disambiguated record
Ke Ding
Also filed as: DING KE
18 granted patents·13 pending applications·114 citations·filing 2006–2024
91Inventor score
Files withDING KE3GUANGZHOU INST BIOMED & HEALTH3UNIV JINAN3WANG SHAOMENG3WANHUA CHEMICAL GROUP CO LTD3
Top patents by PatentIndex Score
31 records- 0197US7759383B2Small molecule inhibitors of MDM2 and the uses thereofUNIV MICHIGAN·Filed 2006·Granted Jul 20, 2010·57 cites·9 claims
- 0294US8088931B2Small molecule inhibitors of MDM2 and the uses thereofWANG SHAOMENG·Filed 2010·Granted Jan 3, 2012·28 cites·8 claims
- 0386US8846671B2Heterocyclic alkynyl benzene compounds and medical compositions and uses thereofDING KE·Filed 2011·Granted Sep 30, 2014·11 cites·11 claims
- 0486US8742121B2Process for the preparation of small molecule inhibitors of MDM2 and intermediates used thereinWANG SHAOMENG·Filed 2012·Granted Jun 3, 2014·3 cites·16 claims
- 0582US10155756B2Pyrazolo[1,5-A]pyridine compounds and use thereofGUANGZHOU INST BIOMED & HEALTH·Filed 2015·Granted Dec 18, 2018·5 cites·11 claims
- 0681US8901117B2Small molecule inhibitors of MDM2 and the uses thereofWANG SHAOMENG·Filed 2011·Granted Dec 2, 2014·2 cites·7 claims
- 0777US2025170125A1Novel application of gzd824 and pharmaceutically acceptable salts thereof in treating diseasesGUANGZHOU HEALTHQUEST PHARMA CO LTD·Filed 2024·Application pending·0 cites
- 0875US11192890B2FGFR kinase inhibitors and pharmaceutical usesAUCKLAND UNISERVICES LTD·Filed 2018·Granted Dec 7, 2021·2 cites·22 claims
- 0975US10370360B2Small-molecule inhibitors targeting discoidin domain receptor 1 and uses thereofUNIV TEXAS·Filed 2015·Granted Aug 6, 2019·3 cites·19 claims
- 1073US10898883B2Silicalite-1 molecular sieve-based catalyst and preparation method for 1,2-pentanediol using said catalystWANHUA CHEMICAL GROUP CO LTD·Filed 2017·Granted Jan 26, 2021·1 cites·21 claims
- 1168US10683278B2Substituted quinolone derivatives, or pharmaceutically acceptable salts or stereoisomers thereof, and pharmaceutical compositions and use thereofUNIV JINAN·Filed 2016·Granted Jun 16, 2020·1 cites·11 claims
- 1265US2025100994A1Cdk12/13 covalent inhibitors or pharmaceutical composition thereof, and uses thereofUNIV MICHIGAN REGENTS·Filed 2024·Application pending·0 cites
- 1364US10059694B22-aminopyrimidine compound and pharmaceutical composition and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2015·Granted Aug 28, 2018·1 cites·15 claims
- 1464US2021228573A1Novel application of gzd824 and pharmaceutically acceptable salts thereof in treating diseasesHEALTHQUEST PHARMA INC·Filed 2021·Application pending·0 cites
- 1563US2024132492A1Pyridopyrimidine-based compound and application thereofUNIV JINAN·Filed 2023·Application pending·0 cites
- 1659US2023348487A12-aminopyrimidine compound and pharmaceutical composition thereof and application thereofGUANGZHOU SALUSTIER BIOSCIENCES CO LTD·Filed 2023·Application pending·0 cites
- 1755US2022281821A1Indazole compounds and their pharmaceutical compositionsUNIV JINAN·Filed 2022·Application pending·0 cites
- 1853US8853221B2Compounds of estrogen-related receptor modulators and the uses thereofDING KE·Filed 2009·Granted Oct 7, 2014·0 cites·3 claims
- 1951US9353089B2Compositions and methods for the treatment of malariaUNIV SAINT LOUIS·Filed 2014·Granted May 31, 2016·0 cites·8 claims
- 2050US11834454B2Alkynylphenylbenzamide compounds and applications thereofSHENZHEN NEWDEL BIOTECH CO LTD·Filed 2022·Granted Dec 5, 2023·0 cites·15 claims
- 2150US2020330456A1Novel application of gzd824 and pharmaceutically acceptable salts thereof in treating diseasesHEALTHQUEST PHARMA INC·Filed 2017·Application pending·0 cites
- 2249US11603392B2Vault particles having a modified R8 flexible regionUNIV CALIFORNIA·Filed 2018·Granted Mar 14, 2023·0 cites·24 claims
- 2347US10974233B2Catalyst for preparing 1,5-pentanediol via hydrogenolysis of tetrahydrofurfuryl alcohol, method and application thereofWANHUA CHEMICAL GROUP CO LTD·Filed 2017·Granted Apr 13, 2021·0 cites·15 claims
- 2445US9452220B2Coupling compounds of NSAID anti-inflammatory and analgesic drugs and EGFR kinase inhibitors, synthesis methods and applications thereofGUANGZHOU INST BIOMED & HEALTH·Filed 2014·Granted Sep 27, 2016·0 cites·3 claims
- 2543US2006247305A1Chromen-4-one inhibitors of anti-apoptotic Bcl-2 family members and the uses thereofUNIV MICHIGAN·Filed 2006·Application pending·0 cites
- 2641US11389780B2Reaction system, catalyst and method for preparing β-phenylethanolWANHUA CHEMICAL GROUP CO LTD·Filed 2017·Granted Jul 19, 2022·0 cites·20 claims
- 2741US2022041591A1Compounds for treating diabetes and/or related conditionsAUCKLAND UNISERVICES LTD·Filed 2019·Application pending·0 cites
- 2838US2014296216A1Pyrimido[4,5-d]pyrimidinyl compounds, pharmaceutical compositions and uses thereofDING KE·Filed 2011·Application pending·0 cites
- 2937US2015011544A1Compounds of estrogen-related receptor modulators and the uses thereofGUANGZHOU INST OF BIOMEDICINE & HEALTH CHINESE ACADEMY OF SCIENCES·Filed 2014·Application pending·0 cites
- 3032US2021078972A1Quinoline or quinazoline compound and application thereofHAIHE BIOPHARMA CO LTD·Filed 2019·Application pending·0 cites
- 3126US2011071148A1Compounds as the estrogen related receptors modulators and the uses thereofGUANGZHOU INST BIOMED & HEALTH·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ke Ding files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →